Wednesday, July 1, 2015 Daily Archives

EMD Millipore Expands ProvantageĀ® Biodevelopment Services with Addition of ProvantageĀ® Clone Generation Service

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today announced expansion of its ProvantageĀ® Biodevelopment Services to include a Clone Generation Service. With this addition, the Company now provides a full range of services for optimizing yield, productivity, consistency and efficiency of clinical scale drug products. The new Clone Generation Service includes expression of recombinant proteins such as hormones, growth factors and mono- and bi-specific monoclonal antibodies. Customers can choose from DG44 and CHO-S cell lines,…

EMD Millipore Introduces the MobiusĀ® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use

EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today introduced the MobiusĀ® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the MobiusĀ® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience. With configurable software, hardware, and single-use FlexwareĀ® assemblies for suspension and adherent cell culture applications, the new 2000 liter single-use bioreactor incorporates industry-leading design features that enable users to easily optimize their upstream process. The…